| Title | CNS oncology |
| Abbreviation | CNS oncol. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Neurology (Q1); Neurology (clinical) (Q1) |
| h-index | 34 |
| Overall Rank/Ranking | 3981 |
| SCImago Journal Rank (SJR) | 1.123 |
| Impact Score | 2.65 |
| Publisher | Taylor and Francis Ltd. |
| Country | United Kingdom |
| ISSN | 20450915, 20450907 |
| Best Quartile | Q1 |
| Coverage History | 2012-2024 |
CNS oncology is a journal covering the technologies/fields/categories related to Neurology (Q1); Neurology (clinical) (Q1). It is published by Taylor and Francis Ltd.. The overall rank of CNS oncology is 3981. According to SCImago Journal Rank (SJR), this journal is ranked 1.123. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 34. The best quartile for this journal is Q1.
The ISSN of CNS oncology journal is 20450915, 20450907. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. CNS oncology is cited by a total of 131 articles during the last 3 years (Preceding 2024).
The Impact IF 2024 of CNS oncology is 2.65, which is computed in 2025 as per its definition. CNS oncology IF is decreased by a factor of 0.39 and approximate percentage change is -12.83% when compared to preceding year 2023, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2024 of CNS oncology is 2.65. If the same downward trend persists, Impact IF may fall in 2025 as well.
| Year | Impact IF |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 2.65 |
| 2023 | 3.04 |
| 2022 | 2.00 |
| 2021 | 3.57 |
| 2020 | 3.33 |
| 2019 | 2.00 |
| 2018 | 1.85 |
| 2017 | 1.70 |
| 2016 | 1.29 |
| 2015 | 0.93 |
| 2014 | 0.59 |
CNS oncology has an h-index of 34. It means 34 articles of this journal have more than 34 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of CNS oncology is 20450915, 20450907. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of CNS oncology is 3981. According to SCImago Journal Rank (SJR), this journal is ranked 1.123. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 1.123 |
| 2023 | 0.64 |
| 2022 | 1.088 |
| 2021 | 0.921 |
| 2020 | 0.866 |
| 2019 | 0.648 |
| 2018 | 0.691 |
| 2017 | 0.502 |
| 2016 | 0.498 |
| 2015 | 0.395 |
| 2014 | 0.308 |
| Year | Ranking |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 3981 |
| 2023 | 8334 |
| 2022 | 3659 |
| 2021 | 4637 |
| 2020 | 5392 |
| 2019 | 7588 |
| 2018 | 6965 |
| 2017 | 9174 |
| 2016 | 9305 |
| 2015 | 11010 |
| 2014 | 12767 |
CNS oncology is published by Taylor and Francis Ltd.. It's publishing house is located in United Kingdom. Coverage history of this journal is as following: 2012-2024. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of CNS oncology is CNS oncol.. This abbreviation ('CNS oncol.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Neurology (Q1); Neurology (clinical) (Q1), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
CNS oncology latest impact IF is 2.65. It's evaluated in the year 2024. The highest and the lowest impact IF or impact score of this journal are 3.57 (2021) and 0.59 (2014), respectively, in the last 11 years. Moreover, its average IS is 2.09 in the previous 11 years.
The CNS oncology has an SJR (SCImago Journal Rank) of 1.123, according to the latest data. It is computed in the year 2025. In the past 11 years, this journal has recorded a range of SJR, with the highest being 1.123 in 2024 and the lowest being 0.308 in 2014. Furthermore, the average SJR of the CNS oncology over the previous 11-year period stands at 2.09.
The latest h-index of the CNS oncology is 34.
The CNS oncology is published by the Taylor and Francis Ltd., with its country of publication being the United Kingdom.
The CNS oncology is currently ranked 3981 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 11 years, this journal has experienced varying rankings, reaching its highest position of 3659 in 2022 and its lowest position of 12767 in 2014.
The standard ISO4 abbreviation for the CNS oncology is CNS oncol..
CNS oncology is classified as a journal that the Taylor and Francis Ltd. publishes.
The CNS oncology encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The CNS oncology is assigned the following International Standard Serial Numbers (ISSN): 20450915, 20450907.
The best quartile for the CNS oncology is Q1 (2024).
The CNS oncology coverage history can be summarized as follows: 2012-2024.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Business: Theory and Practice | journal | 16073 | Vilnius Gediminas Technical University | 31 | 2.45 |
| Current Sociology | journal | 5151 | SAGE Publications Ltd | 86 | 3.02 |
| Journal of Applied Business Research | journal | 26260 | Clute Institute | 33 | 0.17 |
| World Englishes | journal | 7267 | Wiley-Blackwell | 68 | 2.38 |
| Sex Education | journal | 6348 | Routledge | 51 | 2.49 |
| Transnational Corporations | journal | 13970 | UNCTAD United Nations Conference on Trade and Development | 30 | 1.63 |
| Statistica | journal | 18529 | University of Bologna | 9 | 0.38 |
| Built Environment | journal | 16252 | Alexandrine Press | 51 | 0.95 |
| Genes and Nutrition | journal | 4763 | BioMed Central Ltd | 69 | 4.26 |
| Proceedings of the Royal Society of Queensland | journal | 28017 | Royal Society of Queensland | 12 | 0.17 |
| Year | Impact Score (IS) |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 2.65 |
| 2023 | 3.04 |
| 2022 | 2.00 |
| 2021 | 3.57 |
| 2020 | 3.33 |
| 2019 | 2.00 |
| 2018 | 1.85 |
| 2017 | 1.70 |
| 2016 | 1.29 |
| 2015 | 0.93 |
| 2014 | 0.59 |
